Best CT (computer tomography) doctors: TOP 532 doctors

Professional experience

Since 2006, he has been Head of the Neurology Department at the Quironsalud University Hospital of Madrid and the Ruber Juan Bravo Hospital.

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid, holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

Doctor of Medicine, Complutense University of Madrid (UCM). Award for Outstanding Doctoral Thesis (UCM, 2004): Study on the relationship of human herpes virus 6 as an environmental factor in multiple sclerosis.

Membership in scientific societies

National and International Principal Investigator in Neuroscience at Quironsalud Madrid (June 2015 – present)

President of the Research Committee of the Quironsalud University Hospital of Madrid (2012 to present).

Member of the Research Committee of the San Carlos Clinical Hospital (2012-2015).

Member of the Council of the Faculty of Medicine of the Complutense University of Madrid (2011-2015).

Research and Teaching

Principal investigator of 100 national and international clinical trials.

7 FIS research projects from the Carlos III Institute of Health (the last 5 as principal investigator).

10 projects from private foundations, received on a competitive basis (7 as principal investigator).

He has authored 139 international articles with a total impact factor of 949,917 and 4,552 citations. 38 books and book chapters with an H-factor of 34 (2018).

His publications stand out in journals that have the greatest global impact on research, such as the New England Journal of Medicine and the Lancet.

Dr. Rafael Arroyo has given over 300 international and national presentations at various Congresses.

Education :

Professor of Medicine at the Faculty of Biomedical Sciences of the European University of Madrid and holds the national accreditation of Professor of Medical Sciences (issued by ANECA).

1997 - 2002 Istanbul University Cerrahpaşa Faculty of Medicine, Department of Orthopedics and Traumatology

1990 - 1996 Istanbul University Cerrahpasa Faculty of Medicine

Articles he wrote and contributed to;

Clinical efficacy of peritendinous platelet-rich plasma injection in the treatment of tendinopathies: A retrospective study Aybars Kıvrak* (a), Mehmet Can Ünlü (a), Esref Terzi (a), Olgar Birsel (b), Doruk Akgun (c), Yusuf Pirincci (d), Gokhan Kaynak(a), Isik Akgun (e) Medium and long-term effects of acetabular roof ring and Burch-Schneider anti-protusio cages in acetabular revisions in patients with acetabular bone deficiency Correspondence: Yusuf Pirinççi , Muhammed Taha Demir, Mumammet Salih, Fahri Erdoğan, Nejat Güney

Dimensional variables of the proximal femur in developmental adult hip dysplasia suggest that a tapered, rectangular, press-fit design may be an optimal choice for patients with Crowe type IV hips

Specialties

Limb Lenghtening 

Sports Surgery

Meniscus Tears

Anterior Cruciate Ligament Tears

Knee Prosthesis

Hip Prosthesis

Shoulder Prosthesis

Shoulder Slap Repair

Height Extension

Tumor Surgery

Foot Surgery( Hallux Valgus)

Diabetic Foot

Bone Infections (Osteomyelitis)

Education

2005 – 2011 | Kocaeli University, Faculty of Medicine, Kocaeli, Turkey
M.D. Degree

2013 – 2019 | Erenköy Mental Health and Neurology Training and Research Hospital, Istanbul, Turkey
Neurology Residency Program

Languages

English – Very Advanced

Professional Experience

Artvin Borçka State Hospital, Artvin, Turkey
General Practitioner (Compulsory Service)
2011 – 2012

Erenköy Mental Health and Neurology Training and Research Hospital, Neurology Department, Istanbul, Turkey
Resident Physician
2013 – 2019

Siirt State Hospital, Siirt, Turkey
Neurology Specialist (Compulsory Service)
2019 – March 2021

Private Pendik Medical Park Hospital, Istanbul, Turkey
Neurology Specialist
April 3, 2021 – April 10, 2024

Bahçeşehir University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Assistant Professor
April 19, 2021 – June 1, 2024

Medipol Acıbadem Regional Hospital, Istanbul, Turkey
Associate Professor of Neurology
April 22, 2024 – Present

Istanbul Medipol University Faculty of Medicine, Department of Neurology, Istanbul, Turkey
Associate Professor of Neurology
November 11, 2024 – Present

Memberships

Turkish Neurology Society

Turkish Medical Association

International Parkinson and Movement Disorder Society

Turkish Neurology Society Neurorehabilitation Working Group

Global Migraine and Pain Society

International Headache Society

Turkish Parkinson’s Disease Society

Turkish Alzheimer Association, Kadıköy Branch

Areas of Interest

Parkinson’s disease and other movement disorders

Migraine and other headache disorders

Sleep disorders

Dementia and Alzheimer’s disease

EEG, Polysomnography (PSG), Multiple Sleep Latency Test (MSLT)

Botulinum toxin injections for movement disorders

Nerve blocks and botulinum toxin for headache management

Epilepsy

Dr. Levent Dalar is a respected pulmonologist with over 20 years of experience. He specializes in interventional bronchoscopy and rare lung diseases. Dr. Dalar has trained and worked in France, Switzerland, and Turkey. He gained valuable experience at the University of Zürich’s Lung Transplant Unit. His background gives him a broad view of advanced lung care.

Dr. Dalar is known for his work in bronchoscopic techniques. He has diagnosed and treated thousands of complex respiratory cases. His main focus is on interstitial lung diseases and respiratory deficiencies. As a professor, he helps train future specialists at top universities. He is also an active member of ERS, EABIP, SPLF, and GELF, staying involved in the latest developments in respiratory medicine.

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Education & Expertise

• 1999 to 2005 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Istanbul Kartal Koşuyolu Higher Specialization Education and Research Hospital, Cardiology Specialization

Experience

• 2010 to 2012 – Specialist Doctor, Istanbul Ümraniye Education and Research Hospital
• 2012 to 2014 – Specialist Doctor, Istanbul Tuzla State Hospital
• 2014 to 2017 – Specialist Doctor, Istanbul Kartal Koşuyolu Higher Specialization Education and Research Hospital
• 2017 to 2018 – Associate Professor, Istanbul Kartal Koşuyolu Higher Specialization Education and Research Hospital

Professional Memberships

• Turkish Medical Association (Istanbul Medical Chamber)
• Turkish Society of Cardiology
• European Society of Cardiology (ESC)

Education & Expertise

1995 to 2001 | Ege University Faculty of Medicine – Medical Education

2001 to 2006 | Dokuz Eylül University Faculty of Medicine – Internal Medicine Specialization

2008 to 2011 | Göztepe Training and Research Hospital – Gastroenterology Subspecialty

2014 | Ümraniye Training and Research Hospital – Associate Professor of Gastroenterology

2021 | University of Health Sciences – Professor

Professional Experience

2007 | Nusaybin State Hospital – Internal Medicine Specialist (Civil Service Obligation)

2011 to 2014 | Ümraniye Training and Research Hospital – Gastroenterology Specialist

2014 to 2017 | Ümraniye Training and Research Hospital – Associate Professor of Gastroenterology

2017 to 2021 | Health Sciences University – Associate Professor of Gastroenterology

2015 to 2021 | Ümraniye Training and Research Hospital Gastroenterology Clinic – Clinic Chief

2021 to 2022 | University of Health Sciences – Professor of Internal Medicine and Gastroenterology

2015 to 2022 | Genomic Laboratory (GLAB) Coordinator, Istanbul Provincial Health Directorate

2014 to 2021 | Northern Clinics of Istanbul Journal (indexed in WoS and PubMed) – Founding Editor

2021 to Present | Turkish Liver Research Association – Board Member

2022 to Present | Hepatology Bulletin Journal – Editor

2019 to Present | Hepatology Forum Magazine – Editor

2016 to Present | World Journal of Hepatology – Editor

International Experience

1999 | Trainee Doctor, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

2000 | Trainee Doctor, Cardiology Unit, North Manchester General Hospital, Manchester, UK

2005 | Assistant Doctor, Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK

Professional Memberships

Turkish Gastroenterology Association

Turkish Liver Research Association

EASL – European Association for the Study of Liver

APASL – Asian Pacific Association for the Study of Liver

AAAS – American Association for the Advancement of Science

Awards & Recognitions

2013 | Liver Fibrosis Pathways in Chronic Hepatitis B: A Comparative Proteomic Study – Gilead Fellowship Award

2014 | Liver Fibrosis Pathways in Chronic Hepatitis B: A Comparative Proteomic Study – Viral Hepatitis Fight Association Project Support Award

2014 | The Relationship between Spontaneous Seroconversion and Toll-Like Receptor Gene Polymorphism in Hepatitis B Infection – Turkish Gastroenterology Association, Best Poster Second Prize

2015 | Research on Damage Pathways in Liver Tissue in Chronic Hepatitis B: A Comparative Proteomic Study – Turkish Gastroenterology Association, Best Oral Presentation Third Prize

2016 | Investigations of the EGF and Its Receptor EGFR Gene Variants in Ulcerative Colitis – XV Euroasian Congress of Gastroenterology and Surgery, Best Oral Presentation Third Prize

Education and Expertise

1988: Istanbul University Cerrahpaşa Faculty of Medicine, Medical Education, Istanbul

1996: Haydarpaşa Numune Training and Research Hospital, Brain and Neurosurgery Clinic, Neurosurgery Specialist Training, Istanbul

Experience

1989 to 1996: Haydarpaşa Numune Training and Research Hospital, Brain and Neurosurgery Clinic, Assistant Doctor, Istanbul

1996 to 1999: Private Respect Hospital, Specialist Doctor and Chief Physician, Istanbul

2000 to 2002: Bakırköy Mental and Neurological Diseases Training and Research Hospital, 1st Neurosurgery Clinic, Specialist Doctor, Istanbul

2002 to 2010: Ministry of Health Pendik State Hospital, Specialist Doctor, Istanbul

2008 to 2009: Participation in "Spinal Surgery Program" at Istanbul American Hospital Neurosurgery Clinic. Fellowship Days: 01.05.2008 - 31.12.2009

2010 to 2011: University of California Los Angeles (UCLA), Santa Monica Hospital Center for Spinal Surgery (Comprehensive Spine Center), Researcher (Fellow), California, USA

2011: Associate Professor

2014: Virginia University Faculty of Medicine, Department of Brain and Neurosurgery, Visiting Faculty Member, Charlottesville, Virginia, USA

2012 to 2016: Istanbul Medeniyet University Faculty of Medicine, Department of Brain and Neurosurgery, Istanbul

2016 to 2018: Vital Fulya Plaza, Fulya/Beşiktaş/Istanbul

Professional Memberships

-Turkish Neurosurgery Association
-Turkish Neurosurgery Association, Spinal and Peripheral Nerve Surgery Teaching and Training Group
-Turkish Spine Association
-AO Spine International
-Society for Minimal Intervention in Spinal Surgery
-Turkish Neurosurgery Association, Surgical Neurosurgery Group
-Scoliosis Research Society (SRS)

 

Dr. Ju-wan Seok is a neurosurgeon. He earned his M.D. from Hanyang University College of Medicine. He completed his internship and neurosurgery residency at Hanyang University Hospital. He later worked there as a neurosurgeon.

Dr. Seok is known for his innovative work. He won the 2017 contest for Making Ideas to Use Health Information Big Data. In 2016, he received the Best Fellow Award at Cheongdam Wooridul Spine Hospital.

PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

• Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
• Role: Subinvestigator

2. PFİZER

• Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
• Role: Subinvestigator

3. RECITE - AMGEN

• Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
• Role: Subinvestigator

4. NAVIGATE - BAYER

• Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
• Role: Subinvestigator

5. RUBY - Tesaro (PRA)

• Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
• Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

• Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
• Role: Subinvestigator

7. ASTRA ZENECA

• Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
• Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

• Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
• Role: Subinvestigator
•  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
• Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

• Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
• Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

• Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
• Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

• Authors: Paksoy, Nail, et al.
• Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

• Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
• Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

• Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
• Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

• Authors: HAS SIMSEK, Duygu, et al.
• Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

• Authors: FERHATOGLU, Ferhat, et al.
• Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

• Authors: TURAL, Deniz, et al.
• Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

• Authors: GÜRBÜZ, Mustafa, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

• Authors: AY, Seval, et al.
• Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

• Authors: CIL, Ibrahim, et al.
• Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

• Authors: HIZAL, Mutlu, et al.
• Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
• Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

• Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
• Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

• Authors: DEMIR, Semra, et al.
• Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

• Authors: ÖZDEMIR, Seçil Kepil, et al.
• Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

• Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
• Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

• Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
• Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
• Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

• Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
• Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

• Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
• Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

• Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
• Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

• Authors: Dogan, I., Paksoy, N., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

• Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
• Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

• Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
• Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

• Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
• Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

• Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
• Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

• Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
• Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

• Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

• Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

• Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

• Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

• Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

• Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

• Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

• Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

• Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

Dr. Idris Sertbas is a skilled neurosurgeon with experience in both adult and pediatric brain and spine surgeries. He performs complex procedures such as brain and cerebellum tumor surgeries. He also treats children with conditions like hydrocephalus, tethered cord, and craniosynostosis. Dr. Sertbas is experienced in advanced spine surgeries, including stabilization for disc herniation, vertebroplasty, and kyphosis surgery.

He is trained in neuromodulation surgeries, such as deep brain stimulation for Parkinson’s disease, epilepsy stimulation, and spinal cord stimulation for chronic pain. He also performs procedures for trigeminal neuralgia, hemifacial spasm, and baclofen pump implantation for severe spasticity.

Dr. Sertbas graduated from Sivas Cumhuriyet University and completed his neurosurgery training at Ankara Training and Research Hospital. He has worked at Bartın State Hospital and Istanbul Yeni Yüzyıl University. He now practices at the Neurosurgery Clinic of Liv Vadistanbul Hospital.

Dr. Marc Ulrich Becher is an interventional cardiologist and heart failure specialist at Städtisches Klinikum Solingen. He is known for performing advanced procedures such as coronary angiography, radiofrequency ablation with 3D mapping, carotid angioplasty, and stenting.

Dr. Becher’s clinic carries out about 3,000 to 4,000 diagnostic and therapeutic procedures each year. These include complex coronary interventions, catheter-based valve replacements, and structural heart procedures. He is experienced in using advanced imaging techniques like IVUS and OCT for accurate diagnosis and treatment planning.

Dr. Becher is dedicated to providing thorough and compassionate care. He uses modern therapies for both acute and chronic cardiovascular diseases, focusing on patient safety and positive outcomes.

Dr. Ercan Ozden is a specialist in internal medicine and medical oncology. He earned his medical degree and completed his residency at Istanbul University, Cerrahpaşa Faculty of Medicine. He later received a subspecialty in medical oncology at Kocaeli University Faculty of Medicine from 2016 to 2020.

Dr. Ozden has worked in medical oncology at Şırnak State Hospital. He has also served as an internal medicine specialist at Bağcılar Private Safa Hospital and Küçükçekmece Batı Bahat Hospital. He has extensive clinical experience in both internal medicine and oncology.

EDUCATION:

• Turhan and Mediha Tansel Primary School (1979–1984)
• Kültür College (1984–1988)
• Semiha Şakir High School (1988–1991)
• Marmara University Faculty of Medicine (1991–1997)
• Marmara University Faculty of Medicine, Neurosurgery Department, Specialist Training (1997–2002)
• Title of Associate Professor in Neurosurgery (May 31, 2021)

ADDITIONAL TRAINING:

• "Visiting Physician," University of Southern California, Department of Neurosurgery (1998)
• "Microsurgery Training," GATA (Gülhane Military Medical Academy), Ankara Education and Research Hospital (2003)

PROFESSIONAL EXPERIENCE:

• Gülhane Military Medical Academy Haydarpaşa Training and Research Hospital (2002–2003)
• Dr. Lütfi Kırdar Kartal Training and Research Hospital (2003–2005)
• Private Avicenna Ataşehir Hospital (2005–2012)
• Private 29 Mayıs Hospital (2012–2013)
• Maltepe State Hospital (2013–2018)
• Kartal Dr. Lütfi Kırdar City Hospital (2018–2020)
• Private Academic Hospital (2020–2022)
• Hisar Intercontinental Hospital (2022–2024)
• Private Medipol Acıbadem Regional Hospital (2024–Present)

ADMINISTRATIVE AND ACADEMIC ROLES:

• Board Member, Neurosurgical Society (2006–2009)
• Head of the Emergency Department, Maltepe State Hospital (2014–2016)
• Deputy Chief Physician, Private Academic Hospital (2020–2021)
• Advisory Board Member, Beykent University Faculty of Medicine (2018–2024)
• Faculty Member, Galata University Faculty of Health Sciences (2022–2024)
• Director, Continuous Education Center, Galata University (2022–2024)

Membership in societies:

Expert of scientific journals 

Close co-operation with leading surgeons

Membership of the German Medical Association 

Specialities:

Introduction of new and modern techniques in the field of oncological surgery
General and visceral surgery

Minimally invasive surgery

Gastrointestinal oncology surgery

Oncological surgery

Haemorrhoids treatment

Additional clinical specialisation in minimally invasive and hernia surgery

Surgery and transplantation of the pancreas

Work Experience:

2005: Specialist in the field of surgery

2008: Appointed Senior Consultant specialising in pancreatic surgery and transplantation

2010: Coordinator of the Pancreatic Cancer Centre (Oncocert)

2013: Specialist in visceral surgery

2014: Managing Senior Physician, additional clinical specialisation in minimally invasive and hernia surgery

2019: Chief Surgeon of the Colorectal Cancer Centre Bochum (the first certified colorectal cancer centre in Germany and one of the first certified leading colorectal centres in Europe)

2021: Chief Surgeon of the Department of Surgery at the Academic Hospital Solingen

Thanks to the professor and his team, the department has been modernised by introducing modern surgical methods of treatment and especially improved methods of post-operative recovery. The Department of Surgery at the Solingen Clinic is now further expanding its focus on minimally invasive surgery in the direction of robotics. The clinic has allocated a huge budget for the purchase of state-of-the-art equipment in order to offer patients a full range of surgical methods for the treatment of benign and malignant diseases of the oesophagus, lungs, stomach, liver, pancreas and intestines according to current guidelines and using the most modern technical equipment.

Professor Schenker is an active researcher and lecturer. He lectures at medical universities and organises seminars and workshops for colleagues. He cooperates closely with the Cancer Centre, the Pancreatic Cancer Treatment Centre, the Intestinal Cancer Treatment Centre and the Interregional Trauma Centre.

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Birth Date: 22-11-1973

Place of Birth: Hatay-Turkey

Medical Faculty: Marmara University Medical Faculty(1990-1997 )

Cardiology fellowship:Istanbul University Institution of Cardiology:(1998-2003)

Associate Proffesor of cardiology: 2002

Proffessor of Cardiology:2017

Previous Positions

Istanbul University Institution of Cardiology:Fellow of cardiology 1998-2003

Cardiologist : Kastamonu Şerife Bacı State Hospital 2004-2007

Cardiologist: Istanbul Bağcılar Training and Research Hospital 2007- 2012

Associate Proffesor of cardiology: Istanbul Bağcılar Training and Research Hospital 2012-2013

Head of Cardiology Department: University of Health Sciences ,Istanbul Bağcılar Training and Research Hospital 2013-2024

Current Position

Dırector of   Cardiology departemant : Medipol University Acıbadem District  Hospital 2024--

Memberships :

 Turkish Society of Cardiology,(Vice president and president of Scientific comitee), European Society of Cardiology, European Atherosclerosis Society, American Heart Association, American Society of Hypertension, Former president of Turcic world Cardiology Association, 

Academic Interests:

Interventional Cardiology, Structural Heart Disease, Heart failure,

In 2007 he joined the Costa del Sol Hospital and left this position when he obtained an international scholarship that would take him back to San Francisco. In 2010 he moved to Japan to complete his training in the submucosal endoscopic dissection technique that he would later on introduce in Andalusia in 2011, thus becoming one of the pioneers in the performance of this technique in Spain. In 2011 he became the first medical professional in the world to use the 15-mm AXIOS stent in pancreatic fluid collection drainage. In 2018 he began to perform gastroenteroanastomosis with luminal apposition stent in patients with pancreatic cancer and bowel obstruction, thus becoming a pioneer in Andalusia to perform such technique.

He is a coauthor of the reference guides of the European Society of Gastrointestinal Endoscopy on the endoscopic treatment of chronic pancreatitis and non-variceal gastrointestinal haemorrhage.

Professional Experience

Over 24 years' experience

1999 - Degree in Medicine and Surgery. Malaga University, Spain.

2003 to 2006 - Medical Residency in the Digestive System at the Virgen Macarena Hospital in Seville, Spain.

2006 - International Scholar at the California Pacific Medical Center in San Francisco, USA.

2007 – Digestive System Specialist at the Costa del Sol Hospital, Marbella. Spain.

2008 - California Pacific Medical Center in San Francisco, USA.

2009 - Top Reviewer Award received from the Gastrointestinal Endoscopy Journal.

2011 – Pioneer in Spain in the introduction of the submucosal endoscopic dissection technique.

2011 – First professional in the world to use the AXIOS (15mm) stent for pancreatic fluid collection drainage.

2016 - Gold Medal of the Andalusian Society for Digestive Disease (SAPD, in its Spanish abbreviation).

2017 - Fellow of the American College of Gastroenterology (FACG).

2018 - Pioneer in Andalusia to perform gastroenteroanastomosis with luminal apposition stent to treat bowel obstruction.

2019 - Fellow of the American Society for Gastrointestinal Endoscopy (FASGE).

The Digestive System Unit of the Quirónsalud Marbella Hospital offers a patient service portfolio that includes all the clinical aspects of gastroenterology, hepatology, biliary duct and pancreatic disease, as well as the diagnostic and treatment techniques used in this speciality such as abdominal ultrasound, endoscopy and other functional tests.

Our specialists have solid professional backgrounds and the team is highly qualified for the diagnosis and treatment of complex diseases such as conditions related to acidity (gastric ulcers, helicobacter pylori, gastroesophageal reflux disease), enteropathies (Crohn's Disease, ulcerative colitis; coeliac disease...), viral hepatitis, hepatic cirrhosis, pancreatic disease...

The Digestive System Unit of the Quirónsalud Marbella Hospital is a pioneer in the implementation of a specific check-up programme for digestive disease with special attention to the diagnosis and treatment of colon precancerous lesions.

Diseases, treatments and techniques:

• Diagnostic and therapeutic endoscopic ultrasound

• Endoscopic resection techniques (mucosectomy/submucosal dissection)

• Submucosal or third-space endoscopy (POEM and variants)

• Bariatric endoscopy (Apollo Method)